Self-confined catalytic DNA circuit for on-site nonenzymatic amplified microRNA imaging
Biosensors and Bioelectronics · 2026
DOI: 10.1016/j.bios.2025.118265 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2026. Verfasst von Xue Hu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Blood Transfusion Department, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China. Hauptthemen laut MEDLINE: MicroRNAs, Biosensing Techniques, Metal-Organic Frameworks, Liver Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Chongqing Municipal Education Commission, National Natural Science Foundation of China, Natural Science Foundation of Chongqing Municipality.
Abstract (Originalsprache)
MicroRNAs (miRNAs) are critical regulators in cancer biology, yet their low abundance and high sequence similarity pose significant challenges for accurate intracellular detection. Herein, we present a metal-organic frameworks (MOFs) with self-confined catalytic DNA circuit (designated as MSCDC) integrated within a pH-responsive MIL-53(Fe) framework for on-site, nonenzymatic amplified imaging of miRNA-9 in hepatocellular carcinoma (HCC) cells. The MSCDC was synthesized by anchoring double-stemmed DNA hairpin probes onto MIL-53(Fe) through π-π stacking and electrostatic interactions, achieving high probe density and nuclease resistance. The pH-triggered degradation of MIL-53(Fe) facilitated efficient intracellular release of DNA probes, while the self-confined catalytic DNA circuit enabled autonomous, enzyme-free amplification, converting weak miRNA-9 inputs into strong fluorescence outputs. Compared with conventional carriers, the MSCDC exhibited superior probe loading capacity, enhanced serum stability, excellent biocompatibility, and a femtomolar detection limit (0.32 fM). Importantly, the nanoplatform enabled reliable, real-time visualization of oncogenic miRNA-9 in diverse HCC cell lines, yielding results that were highly consistent with qRT-PCR. This work highlights a generalizable self-confined, nonenzymatic nucleic acid amplification strategy for precise intracellular biosensing, thereby opening avenues for early cancer diagnosis and molecular imaging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Blood Transfusion Department, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
- Center for Medical Epigenetics, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, 400016, China.
- College of Pharmacy, Chongqing Medical University, Chongqing, 400016, China.
- College of Pharmacy, Chongqing Medical University, Chongqing, 400016, China. Electronic address: zouhecun@cqmu.edu.cn.
- College of Pharmacy, Chongqing Medical University, Chongqing, 400016, China. Electronic address: zzwcpu@cqmu.edu.cn.
- Center for Medical Epigenetics, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, 400016, China. Electronic address: lsqzzw@cqmu.edu.cn.
Förderung
- Chongqing Municipal Education Commission
- National Natural Science Foundation of China
- Natural Science Foundation of Chongqing Municipality
Zitieren
APA
Hu, X., Xie, M., Lang, Y., Zhang, J., He, L., Jiang, X., Zou, H., Zhang, Z., & Li, S. (2026). Self-confined catalytic DNA circuit for on-site nonenzymatic amplified microRNA imaging. Biosensors and Bioelectronics. https://doi.org/10.1016/j.bios.2025.118265
Vancouver
Hu X, Xie M, Lang Y, Zhang J, He L, Jiang X, et al. Self-confined catalytic DNA circuit for on-site nonenzymatic amplified microRNA imaging. Biosensors and Bioelectronics. 2026. doi:10.1016/j.bios.2025.118265
BibTeX
@article{Hu2026,
author = {Hu, Xue and Xie, Mingmeng and Lang, Yuxiang and Zhang, Jieyuan and He, Lin and Jiang, Xinhui and Zou, Hecun and Zhang, Zhengwei and Li, Siqiao},
title = {Self-confined catalytic DNA circuit for on-site nonenzymatic amplified microRNA imaging},
journal = {Biosensors and Bioelectronics},
year = {2026},
doi = {10.1016/j.bios.2025.118265}
}
EUVIMED